TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Baau Therapeutics AB
Closing information (x1000 EUR)
Closing information | 2015/12 | 2014/12 | 2013/12 |
Turnover |
12,008
|
8,329
|
0 |
Financial expenses |
0
|
1
|
0 |
Earnings before taxes |
-26
|
1,547
|
184 |
EBITDA |
-10
|
1,719
|
338 |
Total assets |
3,047
|
3,570
|
1,921 |
Current assets |
3,047
|
2,883
|
1,234 |
Current liabilities |
2,929
|
3,255
|
1,608 |
Equity capital |
119
|
271
|
269 |
- share capital |
11
![]() |
11
![]() |
11 |
Employees (average) |
0
|
18
|
17 |
Financial ratios
Fiscal year | 2015/12 | 2014/12 | 2013/12 |
Solvency |
3.9%
|
7.6%
|
14.0% |
Turnover per employee |
463
|
0 | |
Profit as a percentage of turnover |
-0.2%
|
18.6% | |
Return on assets (ROA) |
-0.9%
|
43.4%
|
9.6% |
Current ratio |
104.0%
|
88.6%
|
76.7% |
Return on equity (ROE) |
-21.8%
|
570.8%
|
68.4% |
Change turnover |
3,333
|
8,329
|
0 |
Change turnover % | 38% | ||
Chg. No. of employees |
-18
|
1
![]() |
1 |
Chg. No. of employees % |
-100%
|
6%
![]() |
6% |
Total value of public sale
Fiscal year | 2015/12 | 2014/12 | 2013/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.